Global study aims to sharpen cancer staging for better treatment decisions
NCT ID NCT07013461
First seen May 05, 2026 · Last updated May 09, 2026 · Updated 1 time
Summary
This study aims to improve how doctors classify nasopharyngeal cancer (NPC) to better predict outcomes and guide treatment. Researchers will collect detailed data from 5000 patients worldwide, including those from regions where NPC is common and those where it is rare. Participants will receive standard care and be followed for 5 years. The goal is to refine the TNM staging system and integrate new biomarkers for more personalized treatment planning.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NASOPHARYNGEAL CANCINOMA (NPC) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The University of Hong Kong-Shenzhen Hospital
RECRUITINGShenzhen, Guangdong, 518009, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.